SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '1h9h'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1AQ7_B_AG2B4_1 (TRYPSIN AERUGINOSIN 98-B)	1h9h	TRYPSIN (Sus scrofa)	8 / 8	HIS E 57 ASP E 189 SER E 190 GLN E 192 SER E 195 VAL E 213 GLY E 216 GLY E 226	None	0.48A	1aq7A-1h9hE: 43.5	1aq7A-1h9hE: 82.06
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1BCU_H_PRLH280_0 (ALPHA-THROMBIN)	1h9h	TRYPSIN (Sus scrofa)	6 / 9	ASP E 189 SER E 195 VAL E 213 TRP E 215 GLY E 216 GLY E 226	None	0.43A	1bcuH-1h9hE: 18.4	1bcuH-1h9hE: 38.52
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1DWC_H_MITH1_1 (ALPHA-THROMBIN (LARGE SUBUNIT))	1h9h	TRYPSIN (Sus scrofa)	5 / 9	HIS E 57 ASP E 189 SER E 195 TRP E 215 GLY E 226	None	0.51A	1dwcH-1h9hE: 33.7	1dwcH-1h9hE: 38.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1E7A_B_PFLB4001_1 (SERUM ALBUMIN)	1h9h	TRYPSIN (Sus scrofa)	5 / 9	LEU E 105 ILE E 106 LEU E 209 VAL E 31 GLY E 43	None	1.25A	1e7aB-1h9hE: undetectable	1e7aB-1h9hE: 15.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1EQG_A_IBPA701_1 (PROSTAGLANDIN H2 SYNTHASE-1)	1h9h	TRYPSIN (Sus scrofa)	6 / 9	VAL E 52 LEU E 67 ILE E 63 ALA E 85 SER E 109 LEU E 108	None	1.24A	1eqgA-1h9hE: undetectable	1eqgA-1h9hE: 17.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1EQG_B_IBPB1701_1 (PROSTAGLANDIN H2 SYNTHASE-1)	1h9h	TRYPSIN (Sus scrofa)	6 / 11	VAL E 52 LEU E 67 ILE E 63 ALA E 85 SER E 109 LEU E 108	None	1.24A	1eqgB-1h9hE: undetectable	1eqgB-1h9hE: 17.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1EQH_A_FLPA701_1 (PROSTAGLANDIN H2 SYNTHASE-1)	1h9h	TRYPSIN (Sus scrofa)	6 / 12	VAL E 52 LEU E 67 ILE E 63 ALA E 85 SER E 109 LEU E 108	None	1.19A	1eqhA-1h9hE: 0.0	1eqhA-1h9hE: 17.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1EQH_B_FLPB1701_1 (PROSTAGLANDIN H2 SYNTHASE-1)	1h9h	TRYPSIN (Sus scrofa)	6 / 12	VAL E 52 LEU E 67 ILE E 63 ALA E 85 SER E 109 LEU E 108	None	1.18A	1eqhB-1h9hE: 0.0	1eqhB-1h9hE: 17.41
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1ETR_H_MITH1_1 (EPSILON-THROMBIN)	1h9h	TRYPSIN (Sus scrofa)	8 / 12	HIS E 57 LEU E 99 ASP E 189 SER E 195 VAL E 213 TRP E 215 GLY E 216 GLY E 226	None	0.59A	1etrH-1h9hE: 33.8	1etrH-1h9hE: 38.52
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1F5L_A_AMRA301_1 (UROKINASE-TYPE PLASMINOGEN ACTIVATOR)	1h9h	TRYPSIN (Sus scrofa)	6 / 8	ASP E 189 SER E 190 SER E 195 VAL E 213 GLY E 216 GLY E 226	None	0.39A	1f5lA-1h9hE: 11.7	1f5lA-1h9hE: 37.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1MEH_A_MOAA600_1 (INOSINE-5'-MONOPHOSP HATE DEHYDROGENASE)	1h9h	TRYPSIN (Sus scrofa)	5 / 10	SER E 195 SER E 214 ILE E 212 GLY E 211 GLY E 226	None	1.27A	1mehA-1h9hE: undetectable	1mehA-1h9hE: 19.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1R5L_A_VIVA301_0 (PROTEIN (ALPHA-TOCOPHEROL TRANSFER PROTEIN))	1h9h	TRYPSIN (Sus scrofa)	5 / 12	ILE E 242 ILE E 47 VAL E 121 ILE E 212 ILE E 238	None	1.33A	1r5lA-1h9hE: undetectable	1r5lA-1h9hE: 20.44
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1TNL_A_TPAA900_1 (TRYPSIN)	1h9h	TRYPSIN (Sus scrofa)	6 / 6	ASP E 189 SER E 190 SER E 195 VAL E 213 GLY E 216 GLY E 226	None	0.28A	1tnlA-1h9hE: 43.0	1tnlA-1h9hE: 82.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2OTF_A_2TNA201_1 (PHOSPHOLIPASE A2 VRV-PL-VIIIA)	1h9h	TRYPSIN (Sus scrofa)	4 / 5	LEU E 155 ILE E 73 SER E 32 GLY E 43	None	0.94A	2otfA-1h9hE: undetectable	2otfA-1h9hE: 17.39
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2OTV_A_NCAA1301_0 (CATIONIC TRYPSIN)	1h9h	TRYPSIN (Sus scrofa)	6 / 6	ASP E 189 SER E 190 SER E 195 VAL E 213 GLY E 216 GLY E 226	None	0.25A	2otvA-1h9hE: 43.0	2otvA-1h9hE: 82.06
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2P16_A_GG2A298_1 (COAGULATION FACTOR X (EC 3.4.21.6) (STUART FACTOR) (STUART-PROWER FACTOR))	1h9h	TRYPSIN (Sus scrofa)	7 / 12	ASP E 189 SER E 195 VAL E 213 TRP E 215 GLY E 216 GLY E 226 TYR E 228	None	0.34A	2p16A-1h9hE: 36.0	2p16A-1h9hE: 37.97
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2VIN_A_505A1247_1 (UROKINASE-TYPE PLASMINOGEN ACTIVATOR CHAIN B)	1h9h	TRYPSIN (Sus scrofa)	6 / 8	ASP E 189 SER E 190 SER E 195 VAL E 213 GLY E 216 GLY E 226	None	0.36A	2vinA-1h9hE: 10.8	2vinA-1h9hE: 37.35
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2W26_A_RIVA1001_1 (ACTIVATED FACTOR XA HEAVY CHAIN)	1h9h	TRYPSIN (Sus scrofa)	8 / 12	ASP E 189 SER E 195 VAL E 213 TRP E 215 GLY E 216 GLY E 219 GLY E 226 TYR E 228	None	0.38A	2w26A-1h9hE: 12.7	2w26A-1h9hE: 37.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2XNR_A_ACTA1001_0 (NUCLEAR POLYADENYLATED RNA-BINDING PROTEIN 3)	1h9h	TRYPSIN (Sus scrofa)	3 / 3	SER E 127 ARG E 125 GLN E 204	None	1.02A	2xnrA-1h9hE: undetectable	2xnrA-1h9hE: 15.62
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3GY3_A_PNTA246_0 (CATIONIC TRYPSIN)	1h9h	TRYPSIN (Sus scrofa)	10 / 11	HIS E 57 LEU E 99 GLN E 175 ASP E 189 SER E 190 GLN E 192 SER E 195 TRP E 215 GLY E 216 GLY E 226	None	0.47A	3gy3A-1h9hE: 43.3	3gy3A-1h9hE: 82.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3MB5_A_SAMA301_0 (SAM-DEPENDENT METHYLTRANSFERASE)	1h9h	TRYPSIN (Sus scrofa)	5 / 12	ILE E 212 VAL E 213 GLY E 44 ALA E 55 ILE E 73	None	1.01A	3mb5A-1h9hE: undetectable	3mb5A-1h9hE: 18.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3NVK_I_SAMI228_0 (FIBRILLARIN-LIKE RRNA/TRNA 2'-O-METHYLTRANSFERA SE)	1h9h	TRYPSIN (Sus scrofa)	5 / 12	LYS E 16 GLY E 197 ILE E 212 ALA E 55 ASP E 194	None	1.02A	3nvkI-1h9hE: undetectable	3nvkI-1h9hE: 20.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3PGH_C_FLPC701_1 (CYCLOOXYGENASE-2)	1h9h	TRYPSIN (Sus scrofa)	5 / 12	VAL E 52 LEU E 67 ALA E 85 SER E 109 LEU E 108	None	0.99A	3pghC-1h9hE: 0.0	3pghC-1h9hE: 17.19
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3RXF_A_4APA9_1 (CATIONIC TRYPSIN)	1h9h	TRYPSIN (Sus scrofa)	6 / 6	SER E 190 SER E 195 VAL E 213 TRP E 215 GLY E 216 GLY E 226	None	0.36A	3rxfA-1h9hE: 43.7	3rxfA-1h9hE: 82.06
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3RXH_A_HSMA7_1 (CATIONIC TRYPSIN)	1h9h	TRYPSIN (Sus scrofa)	5 / 5	ASP E 189 SER E 190 SER E 195 VAL E 213 GLY E 226	None	0.34A	3rxhA-1h9hE: 43.6	3rxhA-1h9hE: 82.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3W67_D_VIVD301_0 (ALPHA-TOCOPHEROL TRANSFER PROTEIN)	1h9h	TRYPSIN (Sus scrofa)	5 / 12	ILE E 242 ILE E 47 VAL E 121 LEU E 209 ILE E 212	None	1.14A	3w67D-1h9hE: undetectable	3w67D-1h9hE: 20.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3W9T_F_W9TF512_1 (HEMOLYTIC LECTIN CEL-III)	1h9h	TRYPSIN (Sus scrofa)	4 / 6	THR E 144 ASN E 143 GLY E 193 ILE E 73	None	0.80A	3w9tF-1h9hE: 0.0	3w9tF-1h9hE: 19.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4ACB_B_DXCB1473_0 (TRANSLATION ELONGATION FACTOR SELB)	1h9h	TRYPSIN (Sus scrofa)	4 / 8	ILE E 212 GLY E 211 VAL E 52 GLN E 30	None	0.90A	4acbB-1h9hE: undetectable 4acbC-1h9hE: undetectable	4acbB-1h9hE: 18.18 4acbC-1h9hE: 18.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4EOH_A_TEPA402_1 (PYRIDOXAL KINASE)	1h9h	TRYPSIN (Sus scrofa)	4 / 5	SER E 195 GLY E 43 THR E 229 VAL E 53	None	1.12A	4eohA-1h9hE: undetectable	4eohA-1h9hE: 20.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4FU8_A_ACTA302_0 (UROKINASE-TYPE PLASMINOGEN ACTIVATOR)	1h9h	TRYPSIN (Sus scrofa)	4 / 5	HIS E 57 GLN E 192 GLY E 193 SER E 195	None	0.83A	4fu8A-1h9hE: 34.7	4fu8A-1h9hE: 36.59
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4HFP_B_15UB402_1 (PROTHROMBIN)	1h9h	TRYPSIN (Sus scrofa)	5 / 12	HIS E 57 LEU E 99 ASP E 189 GLY E 216 GLY E 226	None	0.36A	4hfpB-1h9hE: 34.1	4hfpB-1h9hE: 38.13
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4HFP_D_15UD402_1 (PROTHROMBIN)	1h9h	TRYPSIN (Sus scrofa)	6 / 12	HIS E 57 LEU E 99 ASP E 189 VAL E 213 TRP E 215 GLY E 226	None	0.37A	4hfpD-1h9hE: 33.6	4hfpD-1h9hE: 38.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4PH9_A_IBPA601_1 (PROSTAGLANDIN G/H SYNTHASE 2)	1h9h	TRYPSIN (Sus scrofa)	5 / 10	VAL E 52 LEU E 67 ALA E 85 SER E 109 LEU E 108	None	0.95A	4ph9A-1h9hE: 0.0	4ph9A-1h9hE: 17.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4PH9_B_IBPB601_1 (PROSTAGLANDIN G/H SYNTHASE 2)	1h9h	TRYPSIN (Sus scrofa)	5 / 10	VAL E 52 LEU E 67 ALA E 85 SER E 109 LEU E 108	None	0.94A	4ph9B-1h9hE: undetectable	4ph9B-1h9hE: 17.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QDJ_A_SAMA301_0 (MAGNESIUM-PROTOPORPH YRIN O-METHYLTRANSFERASE)	1h9h	TRYPSIN (Sus scrofa)	5 / 12	VAL E 231 GLY E 44 ILE E 103 LEU E 105 LEU E 46	None	1.04A	4qdjA-1h9hE: undetectable	4qdjA-1h9hE: 19.62
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4RN6_B_15UB301_1 (THROMBIN HEAVY CHAIN)	1h9h	TRYPSIN (Sus scrofa)	6 / 12	HIS E 57 LEU E 99 VAL E 213 TRP E 215 GLY E 216 GLY E 226	None	0.31A	4rn6B-1h9hE: 28.1	4rn6B-1h9hE: 38.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5N8J_E_DVAE7_0 (GLY-DTY-GLY-DLE-DAL- DSG-DVA-DAS-DGL-DSN- DSN-GLY STREPTAVIDIN)	1h9h	TRYPSIN (Sus scrofa)	3 / 3	TYR E 217 SER E 171 TRP E 215	None	0.84A	5n8jB-1h9hE: 0.0	5n8jB-1h9hE: 22.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5N8J_O_DVAO7_0 (GLY-DTY-GLY-DLE-DAL- DSG-DVA-DAS-DGL-DSN- DSN-GLY STREPTAVIDIN)	1h9h	TRYPSIN (Sus scrofa)	3 / 3	TYR E 217 SER E 171 TRP E 215	None	0.80A	5n8jA-1h9hE: 0.0	5n8jA-1h9hE: 22.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5N8J_P_DVAP5_0 (GLY-DTY-GLY-DLE-DAL- DSG-DVA-DAS-DGL-DSN- DSN-GLY STREPTAVIDIN)	1h9h	TRYPSIN (Sus scrofa)	3 / 3	TYR E 217 SER E 171 TRP E 215	None	0.80A	5n8jD-1h9hE: 0.0	5n8jD-1h9hE: 22.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5VIM_B_SAMB301_0 (METHYLTRANSFERASE)	1h9h	TRYPSIN (Sus scrofa)	5 / 12	GLY E 142 GLY E 196 GLY E 43 GLY E 140 PHE E 94	None	0.93A	5vimB-1h9hE: undetectable	5vimB-1h9hE: 21.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5VOP_A_C2FA3001_0 (5-METHYLTETRAHYDROFO LATE HOMOCYSTEINE S-METHYLTRANSFERASE)	1h9h	TRYPSIN (Sus scrofa)	5 / 12	GLY E 226 VAL E 53 GLY E 196 SER E 195 ILE E 212	None	1.05A	5vopA-1h9hE: undetectable	5vopA-1h9hE: 20.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6GNE_A_ACRA602_1 (-)	1h9h	TRYPSIN (Sus scrofa)	5 / 12	GLY E 211 VAL E 231 VAL E 53 GLN E 30 GLY E 196	None	1.16A	6gneA-1h9hE: undetectable	6gneA-1h9hE: 18.97

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1AQ7_B_AG2B4_1","TRYPSIN;AERUGINOSIN 98-B","1h9h","TRYPSIN","Sus scrofa",8,"HIS E  57;ASP E 189;SER E 190;GLN E 192;SER E 195;VAL E 213;GLY E 216;GLY E 226","None","0.48A","1aq7A-1h9hE:43.5","1aq7A-1h9hE:82.06"],["1BCU_H_PRLH280_0","ALPHA-THROMBIN","1h9h","TRYPSIN","Sus scrofa",6,"ASP E 189;SER E 195;VAL E 213;TRP E 215;GLY E 216;GLY E 226","None","0.43A","1bcuH-1h9hE:18.4","1bcuH-1h9hE:38.52"],["1DWC_H_MITH1_1","ALPHA-THROMBIN (LARGE SUBUNIT)","1h9h","TRYPSIN","Sus scrofa",5,"HIS E  57;ASP E 189;SER E 195;TRP E 215;GLY E 226","None","0.51A","1dwcH-1h9hE:33.7","1dwcH-1h9hE:38.52"],["1E7A_B_PFLB4001_1","SERUM ALBUMIN","1h9h","TRYPSIN","Sus scrofa",5,"LEU E 105;ILE E 106;LEU E 209;VAL E  31;GLY E  43","None","1.25A","1e7aB-1h9hE:undetectable","1e7aB-1h9hE:15.41"],["1EQG_A_IBPA701_1","PROSTAGLANDIN H2 SYNTHASE-1","1h9h","TRYPSIN","Sus scrofa",6,"VAL E  52;LEU E  67;ILE E  63;ALA E  85;SER E 109;LEU E 108","None","1.24A","1eqgA-1h9hE:undetectable","1eqgA-1h9hE:17.41"],["1EQG_B_IBPB1701_1","PROSTAGLANDIN H2 SYNTHASE-1","1h9h","TRYPSIN","Sus scrofa",6,"VAL E  52;LEU E  67;ILE E  63;ALA E  85;SER E 109;LEU E 108","None","1.24A","1eqgB-1h9hE:undetectable","1eqgB-1h9hE:17.41"],["1EQH_A_FLPA701_1","PROSTAGLANDIN H2 SYNTHASE-1","1h9h","TRYPSIN","Sus scrofa",6,"VAL E  52;LEU E  67;ILE E  63;ALA E  85;SER E 109;LEU E 108","None","1.19A","1eqhA-1h9hE:0.0","1eqhA-1h9hE:17.41"],["1EQH_B_FLPB1701_1","PROSTAGLANDIN H2 SYNTHASE-1","1h9h","TRYPSIN","Sus scrofa",6,"VAL E  52;LEU E  67;ILE E  63;ALA E  85;SER E 109;LEU E 108","None","1.18A","1eqhB-1h9hE:0.0","1eqhB-1h9hE:17.41"],["1ETR_H_MITH1_1","EPSILON-THROMBIN","1h9h","TRYPSIN","Sus scrofa",8,"HIS E  57;LEU E  99;ASP E 189;SER E 195;VAL E 213;TRP E 215;GLY E 216;GLY E 226","None","0.59A","1etrH-1h9hE:33.8","1etrH-1h9hE:38.52"],["1F5L_A_AMRA301_1","UROKINASE-TYPE PLASMINOGEN ACTIVATOR","1h9h","TRYPSIN","Sus scrofa",6,"ASP E 189;SER E 190;SER E 195;VAL E 213;GLY E 216;GLY E 226","None","0.39A","1f5lA-1h9hE:11.7","1f5lA-1h9hE:37.35"],["1MEH_A_MOAA600_1","INOSINE-5'-MONOPHOSPHATE DEHYDROGENASE","1h9h","TRYPSIN","Sus scrofa",5,"SER E 195;SER E 214;ILE E 212;GLY E 211;GLY E 226","None","1.27A","1mehA-1h9hE:undetectable","1mehA-1h9hE:19.35"],["1R5L_A_VIVA301_0","PROTEIN (ALPHA-TOCOPHEROL TRANSFER PROTEIN)","1h9h","TRYPSIN","Sus scrofa",5,"ILE E 242;ILE E  47;VAL E 121;ILE E 212;ILE E 238","None","1.33A","1r5lA-1h9hE:undetectable","1r5lA-1h9hE:20.44"],["1TNL_A_TPAA900_1","TRYPSIN","1h9h","TRYPSIN","Sus scrofa",6,"ASP E 189;SER E 190;SER E 195;VAL E 213;GLY E 216;GLY E 226","None","0.28A","1tnlA-1h9hE:43.0","1tnlA-1h9hE:82.06"],["2OTF_A_2TNA201_1","PHOSPHOLIPASE A2 VRV-PL-VIIIA","1h9h","TRYPSIN","Sus scrofa",4,"LEU E 155;ILE E  73;SER E  32;GLY E  43","None","0.94A","2otfA-1h9hE:undetectable","2otfA-1h9hE:17.39"],["2OTV_A_NCAA1301_0","CATIONIC TRYPSIN","1h9h","TRYPSIN","Sus scrofa",6,"ASP E 189;SER E 190;SER E 195;VAL E 213;GLY E 216;GLY E 226","None","0.25A","2otvA-1h9hE:43.0","2otvA-1h9hE:82.06"],["2P16_A_GG2A298_1","COAGULATION FACTOR X (EC 3.4.21.6) (STUART FACTOR) (STUART-PROWER FACTOR)","1h9h","TRYPSIN","Sus scrofa",7,"ASP E 189;SER E 195;VAL E 213;TRP E 215;GLY E 216;GLY E 226;TYR E 228","None","0.34A","2p16A-1h9hE:36.0","2p16A-1h9hE:37.97"],["2VIN_A_505A1247_1","UROKINASE-TYPE PLASMINOGEN ACTIVATOR CHAIN B","1h9h","TRYPSIN","Sus scrofa",6,"ASP E 189;SER E 190;SER E 195;VAL E 213;GLY E 216;GLY E 226","None","0.36A","2vinA-1h9hE:10.8","2vinA-1h9hE:37.35"],["2W26_A_RIVA1001_1","ACTIVATED FACTOR XA HEAVY CHAIN","1h9h","TRYPSIN","Sus scrofa",8,"ASP E 189;SER E 195;VAL E 213;TRP E 215;GLY E 216;GLY E 219;GLY E 226;TYR E 228","None","0.38A","2w26A-1h9hE:12.7","2w26A-1h9hE:37.97"],["2XNR_A_ACTA1001_0","NUCLEAR POLYADENYLATED RNA-BINDING PROTEIN 3","1h9h","TRYPSIN","Sus scrofa",3,"SER E 127;ARG E 125;GLN E 204","None","1.02A","2xnrA-1h9hE:undetectable","2xnrA-1h9hE:15.62"],["3GY3_A_PNTA246_0","CATIONIC TRYPSIN","1h9h","TRYPSIN","Sus scrofa",10,"HIS E  57;LEU E  99;GLN E 175;ASP E 189;SER E 190;GLN E 192;SER E 195;TRP E 215;GLY E 216;GLY E 226","None","0.47A","3gy3A-1h9hE:43.3","3gy3A-1h9hE:82.06"],["3MB5_A_SAMA301_0","SAM-DEPENDENT METHYLTRANSFERASE","1h9h","TRYPSIN","Sus scrofa",5,"ILE E 212;VAL E 213;GLY E  44;ALA E  55;ILE E  73","None","1.01A","3mb5A-1h9hE:undetectable","3mb5A-1h9hE:18.94"],["3NVK_I_SAMI228_0","FIBRILLARIN-LIKE RRNA\/TRNA 2'-O-METHYLTRANSFERASE","1h9h","TRYPSIN","Sus scrofa",5,"LYS E  16;GLY E 197;ILE E 212;ALA E  55;ASP E 194","None","1.02A","3nvkI-1h9hE:undetectable","3nvkI-1h9hE:20.16"],["3PGH_C_FLPC701_1","CYCLOOXYGENASE-2","1h9h","TRYPSIN","Sus scrofa",5,"VAL E  52;LEU E  67;ALA E  85;SER E 109;LEU E 108","None","0.99A","3pghC-1h9hE:0.0","3pghC-1h9hE:17.19"],["3RXF_A_4APA9_1","CATIONIC TRYPSIN","1h9h","TRYPSIN","Sus scrofa",6,"SER E 190;SER E 195;VAL E 213;TRP E 215;GLY E 216;GLY E 226","None","0.36A","3rxfA-1h9hE:43.7","3rxfA-1h9hE:82.06"],["3RXH_A_HSMA7_1","CATIONIC TRYPSIN","1h9h","TRYPSIN","Sus scrofa",5,"ASP E 189;SER E 190;SER E 195;VAL E 213;GLY E 226","None","0.34A","3rxhA-1h9hE:43.6","3rxhA-1h9hE:82.06"],["3W67_D_VIVD301_0","ALPHA-TOCOPHEROL TRANSFER PROTEIN","1h9h","TRYPSIN","Sus scrofa",5,"ILE E 242;ILE E  47;VAL E 121;LEU E 209;ILE E 212","None","1.14A","3w67D-1h9hE:undetectable","3w67D-1h9hE:20.73"],["3W9T_F_W9TF512_1","HEMOLYTIC LECTIN CEL-III","1h9h","TRYPSIN","Sus scrofa",4,"THR E 144;ASN E 143;GLY E 193;ILE E  73","None","0.80A","3w9tF-1h9hE:0.0","3w9tF-1h9hE:19.42"],["4ACB_B_DXCB1473_0","TRANSLATION ELONGATION FACTOR SELB","1h9h","TRYPSIN","Sus scrofa",4,"ILE E 212;GLY E 211;VAL E  52;GLN E  30","None","0.90A","4acbB-1h9hE:undetectable;4acbC-1h9hE:undetectable","4acbB-1h9hE:18.18;4acbC-1h9hE:18.18"],["4EOH_A_TEPA402_1","PYRIDOXAL KINASE","1h9h","TRYPSIN","Sus scrofa",4,"SER E 195;GLY E  43;THR E 229;VAL E  53","None","1.12A","4eohA-1h9hE:undetectable","4eohA-1h9hE:20.25"],["4FU8_A_ACTA302_0","UROKINASE-TYPE PLASMINOGEN ACTIVATOR","1h9h","TRYPSIN","Sus scrofa",4,"HIS E  57;GLN E 192;GLY E 193;SER E 195","None","0.83A","4fu8A-1h9hE:34.7","4fu8A-1h9hE:36.59"],["4HFP_B_15UB402_1","PROTHROMBIN","1h9h","TRYPSIN","Sus scrofa",5,"HIS E  57;LEU E  99;ASP E 189;GLY E 216;GLY E 226","None","0.36A","4hfpB-1h9hE:34.1","4hfpB-1h9hE:38.13"],["4HFP_D_15UD402_1","PROTHROMBIN","1h9h","TRYPSIN","Sus scrofa",6,"HIS E  57;LEU E  99;ASP E 189;VAL E 213;TRP E 215;GLY E 226","None","0.37A","4hfpD-1h9hE:33.6","4hfpD-1h9hE:38.13"],["4PH9_A_IBPA601_1","PROSTAGLANDIN G\/H SYNTHASE 2","1h9h","TRYPSIN","Sus scrofa",5,"VAL E  52;LEU E  67;ALA E  85;SER E 109;LEU E 108","None","0.95A","4ph9A-1h9hE:0.0","4ph9A-1h9hE:17.03"],["4PH9_B_IBPB601_1","PROSTAGLANDIN G\/H SYNTHASE 2","1h9h","TRYPSIN","Sus scrofa",5,"VAL E  52;LEU E  67;ALA E  85;SER E 109;LEU E 108","None","0.94A","4ph9B-1h9hE:undetectable","4ph9B-1h9hE:17.03"],["4QDJ_A_SAMA301_0","MAGNESIUM-PROTOPORPHYRIN O-METHYLTRANSFERASE","1h9h","TRYPSIN","Sus scrofa",5,"VAL E 231;GLY E  44;ILE E 103;LEU E 105;LEU E  46","None","1.04A","4qdjA-1h9hE:undetectable","4qdjA-1h9hE:19.62"],["4RN6_B_15UB301_1","THROMBIN HEAVY CHAIN","1h9h","TRYPSIN","Sus scrofa",6,"HIS E  57;LEU E  99;VAL E 213;TRP E 215;GLY E 216;GLY E 226","None","0.31A","4rn6B-1h9hE:28.1","4rn6B-1h9hE:38.13"],["5N8J_E_DVAE7_0","GLY-DTY-GLY-DLE-DAL-DSG-DVA-DAS-DGL-DSN-DSN-GLY;STREPTAVIDIN","1h9h","TRYPSIN","Sus scrofa",3,"TYR E 217;SER E 171;TRP E 215","None","0.84A","5n8jB-1h9hE:0.0","5n8jB-1h9hE:22.17"],["5N8J_O_DVAO7_0","GLY-DTY-GLY-DLE-DAL-DSG-DVA-DAS-DGL-DSN-DSN-GLY;STREPTAVIDIN","1h9h","TRYPSIN","Sus scrofa",3,"TYR E 217;SER E 171;TRP E 215","None","0.80A","5n8jA-1h9hE:0.0","5n8jA-1h9hE:22.17"],["5N8J_P_DVAP5_0","GLY-DTY-GLY-DLE-DAL-DSG-DVA-DAS-DGL-DSN-DSN-GLY;STREPTAVIDIN","1h9h","TRYPSIN","Sus scrofa",3,"TYR E 217;SER E 171;TRP E 215","None","0.80A","5n8jD-1h9hE:0.0","5n8jD-1h9hE:22.17"],["5VIM_B_SAMB301_0","METHYLTRANSFERASE","1h9h","TRYPSIN","Sus scrofa",5,"GLY E 142;GLY E 196;GLY E  43;GLY E 140;PHE E  94","None","0.93A","5vimB-1h9hE:undetectable","5vimB-1h9hE:21.81"],["5VOP_A_C2FA3001_0","5-METHYLTETRAHYDROFOLATE HOMOCYSTEINE S-METHYLTRANSFERASE","1h9h","TRYPSIN","Sus scrofa",5,"GLY E 226;VAL E  53;GLY E 196;SER E 195;ILE E 212","None","1.05A","5vopA-1h9hE:undetectable","5vopA-1h9hE:20.13"],["6GNE_A_ACRA602_1","-","1h9h","TRYPSIN","Sus scrofa",5,"GLY E 211;VAL E 231;VAL E  53;GLN E  30;GLY E 196","None","1.16A","6gneA-1h9hE:undetectable","6gneA-1h9hE:18.97"]]